Published in PLoS Med on October 22, 2013
Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis (2014) 2.55
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One (2014) 2.20
How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV. PLoS One (2014) 1.20
Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Eff Resour Alloc (2014) 1.18
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors (2015) 1.14
Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proc Natl Acad Sci U S A (2014) 1.13
Attrition through multiple stages of pre-treatment and ART HIV care in South Africa. PLoS One (2014) 1.06
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health (2015) 1.00
Poor health in rich countries: a role for open access journals. PLoS Med (2013) 0.99
HIV treatment-as-prevention research at a crossroads. PLoS Med (2014) 0.99
Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open (2016) 0.94
HIV self-testing among key populations: an implementation science approach to evaluating self-testing. J Virus Erad (2015) 0.93
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health (2013) 0.87
Modelling the strategic use of antiretroviral therapy for the treatment and prevention of HIV. PLoS Med (2013) 0.86
HIV sexual transmission is predominantly driven by single individuals rather than discordant couples: a model-based approach. PLoS One (2013) 0.86
Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review. Health Econ (2016) 0.85
Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.85
Equity in utilization of antiretroviral therapy for HIV-infected people in South Africa: a systematic review. Int J Equity Health (2014) 0.85
The Art of HIV Elimination: Past and Present Science. J AIDS Clin Res (2015) 0.82
Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action (2016) 0.81
Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012. PLoS One (2016) 0.81
Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making. Int J Infect Dis (2015) 0.81
Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa. PLoS One (2014) 0.80
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. Am J Epidemiol (2016) 0.78
Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa. Clin Infect Dis (2016) 0.78
Impact of Heterogeneity in Sexual Behavior on Effectiveness in Reducing HIV Transmission with Test-and-Treat Strategy. PLoS Comput Biol (2016) 0.77
One in 4 HIV-Positive South Africans Awaiting ART Initiation Report Condomless Sex With a Serodiscordant Partner. J Acquir Immune Defic Syndr (2016) 0.76
Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models. Epidemics (2017) 0.75
The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model. PLoS One (2015) 0.75
Beyond Risk Compensation: Clusters of Antiretroviral Treatment (ART) Users in Sexual Networks Can Modify the Impact of ART on HIV Incidence. PLoS One (2016) 0.75
Operations research in global health: a scoping review with a focus on the themes of health equity and impact. Health Res Policy Syst (2017) 0.75
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis. J Virus Erad (2015) 0.75
Comparison and validation of two computational models of Chagas disease: A thirty year perspective from Venezuela. Epidemics (2017) 0.75
The male factor: Outcomes from a cluster randomized field experiment with a couples-based HIV prevention intervention in a South African township. Drug Alcohol Depend (2016) 0.75
Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study. BMC Infect Dis (2017) 0.75
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. Lancet Glob Health (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet (2009) 6.96
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96
Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol (2007) 6.81
Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis (2011) 5.94
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet (2002) 5.21
Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science (2013) 5.01
Acute HIV-1 Infection. N Engl J Med (2011) 4.84
Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav (1998) 4.81
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS (2010) 4.68
HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS (2002) 4.56
Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ (2002) 4.47
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. Sex Transm Infect (2006) 4.02
Secretive females or swaggering males? An assessment of the quality of sexual partnership reporting in rural Tanzania. Soc Sci Med (2004) 3.79
Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ (2009) 3.77
Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol (2010) 3.72
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis (2002) 3.58
A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One (2010) 3.38
Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med (2005) 3.01
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis (2006) 2.82
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev (2011) 2.52
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28
Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res Hum Retroviruses (2009) 2.09
Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr (2010) 2.05
Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS (2010) 1.88
The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr (2007) 1.88
In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) (2012) 1.84
The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ (2004) 1.76
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One (2011) 1.67
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect (2007) 1.60
Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS (2010) 1.57
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS (2012) 1.55
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS (2011) 1.55
Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS (2000) 1.50
Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS One (2011) 1.43
Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med (2010) 1.41
Ageing with HIV in South Africa. AIDS (2011) 1.37
The economics of scaling up: cost estimation for HIV/AIDS interventions. AIDS (2008) 1.28
Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res Hum Retroviruses (2012) 1.20
Overview and selected findings of sexual behaviour surveys. AIDS (1991) 1.18
HIV drugs for treatment, and for prevention. Lancet (2010) 1.17
The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface (2012) 1.10
Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS (2012) 1.10
Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from Rural South Africa. PLoS One (2010) 1.04
The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda. Sex Transm Infect (2002) 1.03
The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine (2011) 1.00
Elimination of HIV by test and treat: a phantom of wishful thinking? AIDS (2012) 0.98
Role of acute infection in HIV transmission. Lancet (2011) 0.98
Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex Transm Dis (2002) 0.97
A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sex Transm Infect (2009) 0.96
Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study. Hum Resour Health (2012) 0.95
Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa. Sex Transm Infect (2008) 0.90
The role of the health system in HIV treatment-as-prevention. AIDS (2010) 0.86
Focusing strategies of condom use against HIV in different behavioural settings: an evaluation based on a simulation model. Bull World Health Organ (2001) 0.83
Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet (2007) 9.92
Human resources and health outcomes: cross-country econometric study. Lancet (2004) 8.34
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet (2007) 7.90
HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98
Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol (2007) 6.81
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop (2003) 6.64
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis (2004) 5.93
Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet (2011) 5.58
Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS (2007) 5.54
Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science (2013) 5.01
Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis (2005) 4.96
HIV and risk environment for injecting drug users: the past, present, and future. Lancet (2010) 4.77
Programme costs in the economic evaluation of health interventions. Cost Eff Resour Alloc (2003) 4.64
Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ (2002) 4.47
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS (2008) 4.05
Precommitting to serve the underserved. Am J Bioeth (2012) 3.95
Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ (2005) 3.83
Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ (2009) 3.77
Cohort profile: Hlabisa HIV treatment and care programme. Int J Epidemiol (2010) 3.72
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol (2007) 3.69
Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis (2011) 3.63
Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol (2009) 3.42
Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology (2014) 3.39
A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One (2010) 3.38
Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta Trop (2003) 3.16
Equity aspects of the National Health Insurance Scheme in Ghana: Who is enrolling, who is not and why? Soc Sci Med (2010) 3.15
The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population-based study in rural South Africa. AIDS (2007) 3.02
Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS (2007) 3.01
Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health (2008) 3.01
Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS (2008) 2.96
HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol (2010) 2.96
Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2011) 2.96
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA (2002) 2.91
Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One (2009) 2.87
Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis (2007) 2.83
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ (2010) 2.72
Modelling the impact of migration on the HIV epidemic in South Africa. AIDS (2007) 2.63
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One (2009) 2.49
Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav (2008) 2.45
Spatial analysis of hemorrhagic fever with renal syndrome in China. BMC Infect Dis (2006) 2.42
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41
HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One (2008) 2.35
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. PLoS One (2008) 2.23
A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med (2011) 2.23
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS One (2008) 2.14
Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS (2004) 2.10
Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res Hum Retroviruses (2009) 2.09
Women's groups' perceptions of maternal health issues in rural Malawi. Lancet (2006) 2.09
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Global Health (2010) 2.04
Verbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000-2009. Popul Health Metr (2011) 1.98
Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr (2007) 1.97
Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One (2010) 1.96
Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav (2011) 1.95
Intervention to promote exclusive breast-feeding for the first 6 months of life in a high HIV prevalence area. AIDS (2008) 1.95
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm Dis (2006) 1.91
The impact of health insurance in Africa and Asia: a systematic review. Bull World Health Organ (2012) 1.90
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis (2007) 1.88
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS (2013) 1.88
What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS (2002) 1.87
Age-specific mortality patterns in HIV-infected individuals: a comparative analysis of African community study data. AIDS (2007) 1.87
Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res (2007) 1.85
In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment. Health Aff (Millwood) (2012) 1.84
Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study. Sex Transm Dis (2012) 1.83
Poor long-term outcomes for cryptococcal meningitis in rural South Africa. S Afr Med J (2011) 1.83
Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health (2007) 1.82
Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS (2013) 1.82